Bayer had two patents in cybersecurity during Q4 2023. The patent filed by Bayer AG in Q4 2023 describes a system for securely accessing a fluid injection system. This system involves authenticating users, identifying software application features, selecting features, and providing access to the selected feature for accessing the fluid injection system. GlobalData’s report on Bayer gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Bayer grant share with cybersecurity as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: System, method, and computer program product for providing access to fluid injection systems (Patent ID: US20230364325A1)
The patent filed by Bayer AG describes a system for securely accessing a fluid injection system. The system involves at least one processor that authenticates users, provides data on software application features, receives data on selected features, and grants access to the selected feature for accessing the fluid injection system. The processor can display data via a mobile application GUI, determine user authorization based on authentication, and provide access to features based on user authorization levels.
Additionally, the system can display data on the fluid injection system's display screen, access software application features to provide operational data, and log operations data. The patent also includes a computer program product with instructions for user authentication, data provision, feature access, and display via a mobile application GUI. The method for accessing the fluid injection system involves authenticating users, providing software application feature data, receiving selected feature data, and granting access based on user authorization levels. The method can also display data on the system's display screen, access software features for operational data, and provide access based on user authorization.
To know more about GlobalData’s detailed insights on Bayer, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
